During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...
Every time you get sick, your body keeps a record of it. It does so through your immune system, a vast army of cells that mobilizes to fight off diseases. And after the infection is over — if it’s ...
Innate Pharma's Sezary Syndrome treatment shows strong results. Learn why IPHA stock offers potential with phase 2 data and ...
The U.S. Food and Drug Administration (FDA) has approved vimseltinib (RomvimzaTM) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue ...
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...
Researchers indicate that the Lumipulse p-tau217 assay may reduce over 50% of lumbar punctures performed for diagnosing ...
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...
Orca-T with reduced-intensity stem cell transplantation was a safe, feasible alternative to conventional transplant in blood ...
A revolutionary approach to immune therapy has emerged: engineered immune cells that protect healthy tissue without ...
In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...
See a doctor who has experience with it. You’ll find dermatologists who have experience with cutaneous T-cell lymphoma at Find a Dermatologist. Click on "Filters". Select "Any condition" and choose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback